ABBV (STOCKS)
ABBVIE INC.
$217.200000
-4.030000 (-1.82%)
Prev close: $221.230000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert A. Michael
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $382,651.99M
- Employees
- 55,000
- P/E (TTM)
- 109.11
- P/B (TTM)
- -57.46
- Dividend Yield
- 304.66%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
22
Buy
9
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$2.65 | $2.65 | +0.0048 | +0.18% |
|
Dec 2025 (Q4)
|
$2.71 | $2.71 | +0.0047 | +0.17% |
|
Sep 2025 (Q3)
|
$1.86 | $1.81 | +0.0497 | +2.75% |
|
Jun 2025 (Q2)
|
$2.97 | $2.94 | +0.0279 | +0.95% |
Financial Statements
| Revenues | $62.82B |
| Benefits Costs and Expenses | $42.89B |
| Cost Of Revenue | $18.42B |
| Costs And Expenses | $35.41B |
| Gross Profit | $44.40B |
| Operating Expenses | $29.07B |
| Selling, General, and Administrative Expenses | $14.30B |
| Other Operating Expenses | $14.77B |
| Operating Income/Loss | $15.33B |
| Income/Loss From Continuing Operations After Tax | $3.64B |
| Income/Loss From Continuing Operations Before Tax | $19.93B |
| Income Tax Expense/Benefit | $2.33B |
| Income Tax Expense/Benefit, Deferred | -$327.00M |
| Interest Expense, Operating | $2.91B |
| Net Income/Loss | $3.64B |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Net Income/Loss Attributable To Parent | $3.64B |
| Net Income/Loss Available To Common Stockholders, Basic | $3.61B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.00M |
| Preferred Stock Dividends And Other Adjustments | $30.00M |
| Basic Earnings Per Share | $2.03 |
| Diluted Earnings Per Share | $2.03 |
| Basic Average Shares | 5,307,000,000 |
| Diluted Average Shares | 5,318,000,000 |
| Assets | $136.46B |
| Current Assets | $33.53B |
| Inventory | $5.05B |
| Other Current Assets | $28.48B |
| Noncurrent Assets | $102.93B |
| Fixed Assets | $5.69B |
| Intangible Assets | $50.87B |
| Other Non-current Assets | $46.37B |
| Liabilities | $143.08B |
| Current Liabilities | $42.10B |
| Noncurrent Liabilities | $100.98B |
| Equity | -$6.61B |
| Equity Attributable To Noncontrolling Interest | $44.00M |
| Equity Attributable To Parent | -$6.66B |
| Liabilities And Equity | $136.46B |
| Net Cash Flow From Operating Activities | $21.22B |
| Net Cash Flow From Operating Activities, Continuing | $21.22B |
| Net Cash Flow From Investing Activities | -$6.48B |
| Net Cash Flow From Investing Activities, Continuing | -$6.48B |
| Net Cash Flow From Financing Activities | -$10.55B |
| Net Cash Flow From Financing Activities, Continuing | -$10.55B |
| Exchange Gains/Losses | $21.00M |
| Net Cash Flow | $4.22B |
| Net Cash Flow, Continuing | $4.20B |
| Comprehensive Income/Loss | $3.80B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Comprehensive Income/Loss Attributable To Parent | $3.79B |
| Other Comprehensive Income/Loss | $159.00M |